Comparison of single and double autologous stem cell transplantation in multiple myeloma patients

Autologous stem cell transplantation (ASCT) is one of the standard treatments of choice for eligible multiple myeloma (MM) patients. Herein, we aimed to analyze MM patients at our center and compare the clinical outcomes of single and double ASCT patients.

Guardado en:
Detalles Bibliográficos
Autores principales: Malkan Umit Yavuz, Demiroglu Haluk, Buyukasik Yahya, Karatas Ayse, Aladag Elifcan, Goker Hakan
Formato: article
Lenguaje:EN
Publicado: De Gruyter 2021
Materias:
R
Acceso en línea:https://doaj.org/article/3f4e7162eaef4944881f5bd1d9ff437b
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:3f4e7162eaef4944881f5bd1d9ff437b
record_format dspace
spelling oai:doaj.org-article:3f4e7162eaef4944881f5bd1d9ff437b2021-12-05T14:10:54ZComparison of single and double autologous stem cell transplantation in multiple myeloma patients2391-546310.1515/med-2021-0216https://doaj.org/article/3f4e7162eaef4944881f5bd1d9ff437b2021-01-01T00:00:00Zhttps://doi.org/10.1515/med-2021-0216https://doaj.org/toc/2391-5463Autologous stem cell transplantation (ASCT) is one of the standard treatments of choice for eligible multiple myeloma (MM) patients. Herein, we aimed to analyze MM patients at our center and compare the clinical outcomes of single and double ASCT patients.Malkan Umit YavuzDemiroglu HalukBuyukasik YahyaKaratas AyseAladag ElifcanGoker HakanDe Gruyterarticlesecond autologous stem cell transplantationmultiple myelomaMedicineRENOpen Medicine, Vol 16, Iss 1, Pp 192-197 (2021)
institution DOAJ
collection DOAJ
language EN
topic second autologous stem cell transplantation
multiple myeloma
Medicine
R
spellingShingle second autologous stem cell transplantation
multiple myeloma
Medicine
R
Malkan Umit Yavuz
Demiroglu Haluk
Buyukasik Yahya
Karatas Ayse
Aladag Elifcan
Goker Hakan
Comparison of single and double autologous stem cell transplantation in multiple myeloma patients
description Autologous stem cell transplantation (ASCT) is one of the standard treatments of choice for eligible multiple myeloma (MM) patients. Herein, we aimed to analyze MM patients at our center and compare the clinical outcomes of single and double ASCT patients.
format article
author Malkan Umit Yavuz
Demiroglu Haluk
Buyukasik Yahya
Karatas Ayse
Aladag Elifcan
Goker Hakan
author_facet Malkan Umit Yavuz
Demiroglu Haluk
Buyukasik Yahya
Karatas Ayse
Aladag Elifcan
Goker Hakan
author_sort Malkan Umit Yavuz
title Comparison of single and double autologous stem cell transplantation in multiple myeloma patients
title_short Comparison of single and double autologous stem cell transplantation in multiple myeloma patients
title_full Comparison of single and double autologous stem cell transplantation in multiple myeloma patients
title_fullStr Comparison of single and double autologous stem cell transplantation in multiple myeloma patients
title_full_unstemmed Comparison of single and double autologous stem cell transplantation in multiple myeloma patients
title_sort comparison of single and double autologous stem cell transplantation in multiple myeloma patients
publisher De Gruyter
publishDate 2021
url https://doaj.org/article/3f4e7162eaef4944881f5bd1d9ff437b
work_keys_str_mv AT malkanumityavuz comparisonofsingleanddoubleautologousstemcelltransplantationinmultiplemyelomapatients
AT demirogluhaluk comparisonofsingleanddoubleautologousstemcelltransplantationinmultiplemyelomapatients
AT buyukasikyahya comparisonofsingleanddoubleautologousstemcelltransplantationinmultiplemyelomapatients
AT karatasayse comparisonofsingleanddoubleautologousstemcelltransplantationinmultiplemyelomapatients
AT aladagelifcan comparisonofsingleanddoubleautologousstemcelltransplantationinmultiplemyelomapatients
AT gokerhakan comparisonofsingleanddoubleautologousstemcelltransplantationinmultiplemyelomapatients
_version_ 1718371598481752064